Department of Pharmacotherapy and Pharmaceutical Care, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1 Str., 02-097 Warsaw, Poland.
Int J Mol Sci. 2024 Sep 7;25(17):9700. doi: 10.3390/ijms25179700.
Skeletal disorders encompass a wide array of conditions, many of which are associated with short stature. Among these, Desbuquois dysplasia is a rare but severe condition characterized by profound dwarfism, distinct facial features, joint hypermobility with multiple dislocations, and unique vertebral and metaphyseal anomalies. Desbuquois dysplasia is inherited in an autosomal recessive manner, with both the DBQD1 (MIM 251450) and DBQD2 (MIM 615777) forms resulting from biallelic mutations. Specifically, DBQD1 is associated with homozygous or compound heterozygous mutations in the gene, while DBQD2 can result from mutations in either the or genes. This review synthesizes the findings of 111 published case reports, including 54 cases of DBQD1, 39 cases of DBQD2, and 14 cases of the Kim variant (DDKV). Patients in this cohort had a median birth weight of 2505 g, a median length of 40 cm, and a median occipitofrontal circumference of 33 cm. The review highlights the phenotypic variations across Desbuquois dysplasia subtypes, particularly in facial characteristics, joint dislocations, and bone deformities. Genetic analyses revealed a considerable diversity in mutations, with over 35% of cases involving missense mutations, primarily affecting the gene. Additionally, approximately 60% of patients had a history of parental consanguinity, indicating a potential genetic predisposition in certain populations. The identified mutations included deletions, insertions, and nucleotide substitutions, many of which resulted in premature stop codons and the production of truncated, likely nonfunctional proteins. These findings underscore the genetic and clinical complexity of Desbuquois dysplasia, highlighting the importance of early diagnosis and the potential for personalized therapeutic approaches. Continued research is essential to uncover the underlying mechanisms of this disorder and improve outcomes for affected individuals through targeted treatments.
骨骼疾病包括广泛的病症,其中许多与身材矮小有关。在这些疾病中,Desbuquois 发育不良是一种罕见但严重的疾病,其特征是严重的侏儒症、独特的面部特征、多发性关节脱位和关节过度活动、以及独特的椎体和干骺端异常。Desbuquois 发育不良以常染色体隐性方式遗传,DBQD1(MIM 251450)和 DBQD2(MIM 615777)两种形式均由双等位基因突变引起。具体而言,DBQD1 与 基因的纯合子或复合杂合突变相关,而 DBQD2 可由 或 基因的突变引起。本综述综合了 111 篇已发表病例报告的结果,包括 54 例 DBQD1、39 例 DBQD2 和 14 例 Kim 变异型(DDKV)。该队列患者的中位出生体重为 2505 克,中位身长为 40 厘米,中位头围为 33 厘米。该综述强调了 Desbuquois 发育不良亚型之间的表型变异,特别是在面部特征、关节脱位和骨骼畸形方面。遗传分析显示突变具有相当大的多样性,超过 35%的病例涉及错义突变,主要影响 基因。此外,约 60%的患者有父母近亲结婚史,表明某些人群中存在潜在的遗传易感性。已确定的突变包括缺失、插入和核苷酸取代,其中许多导致提前终止密码子和产生截短的、可能无功能的蛋白质。这些发现突出了 Desbuquois 发育不良的遗传和临床复杂性,强调了早期诊断和潜在个性化治疗方法的重要性。持续的研究对于揭示该疾病的潜在机制以及通过靶向治疗改善受影响个体的结局至关重要。